FDA Inspection 985594 — Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals Inc — FEI 3007564743

The FDA completed an inspection of Lexicon Pharmaceuticals Inc on Jul 21, 2016 in Spring, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jul 21, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Spring, TX (United States)

Additional Details

Sponsor, Contract Research Organization